4.7 Article

Novel Hyperactive Transposons for Genetic Modification of Induced Pluripotent and Adult Stem Cells: A Nonviral Paradigm for Coaxed Differentiation

Journal

STEM CELLS
Volume 28, Issue 10, Pages 1760-1771

Publisher

WILEY
DOI: 10.1002/stem.501

Keywords

Transposon; Sleeping Beauty; iPS; Myoblast; Stem cell; Mesenchymal stem cell; Muscle

Funding

  1. EU
  2. AFM
  3. VIB
  4. FWO (Flanders, Belgium
  5. FWO WOG) [G.0632.07, G.0667.07]
  6. KULeuven SCIL Center of Excellence
  7. iWT - Johnson and Johnson Pharmaceutical R&D (Beerse, Belgium)
  8. FWO
  9. AGAURA (Beatriu de Pinos)
  10. COLCIENCIAS/LASPAU
  11. FWO (Beatriu de Pinos)

Ask authors/readers for more resources

Adult stem cells and induced pluripotent stem cells (iPS) hold great promise for regenerative medicine. The development of robust nonviral approaches for stem cell gene transfer would facilitate functional studies and potential clinical applications. We have previously generated hyperactive transposases derived from Sleeping Beauty, using an in vitro molecular evolution and selection paradigm. We now demonstrate that these hyperactive transposases resulted in superior gene transfer efficiencies and expression in mesenchymal and muscle stem/progenitor cells, consistent with higher expression levels of therapeutically relevant proteins including coagulation factor IX. Their differentiation potential and karyotype was not affected. Moreover, stable transposition could also be achieved in iPS, which retained their ability to differentiate along neuronal, cardiac, and hepatic lineages without causing cytogenetic abnormalities. Most importantly, transposon-mediated delivery of the myogenic PAX3 transcription factor into iPS coaxed their differentiation into MYOD+ myogenic progenitors and multinucleated myofibers, suggesting that PAX3 may serve as a myogenic molecular switch in iPS. Hence, this hyperactive transposon system represents an attractive nonviral gene transfer platform with broad implications for regenerative medicine, cell and gene therapy. STEM CELLS 2010; 28: 1760-1771

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available